AP906A - Dofetilide polymorphs - Google Patents

Dofetilide polymorphs Download PDF

Info

Publication number
AP906A
AP906A APAP/P/1998/001371A AP9801371A AP906A AP 906 A AP906 A AP 906A AP 9801371 A AP9801371 A AP 9801371A AP 906 A AP906 A AP 906A
Authority
AP
ARIPO
Prior art keywords
dofetilide
polymorph
dofetilide polymorph
pharmaceutically acceptable
heart failure
Prior art date
Application number
APAP/P/1998/001371A
Other languages
English (en)
Other versions
AP9801371A0 (en
Inventor
Ian Colin Appleby
Trevor Jack Newbury
Gary Nicholas
Original Assignee
Pfizer Res & Development Company N V /S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10821150&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP906(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Res & Development Company N V /S A filed Critical Pfizer Res & Development Company N V /S A
Publication of AP9801371A0 publication Critical patent/AP9801371A0/xx
Application granted granted Critical
Publication of AP906A publication Critical patent/AP906A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrrole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
APAP/P/1998/001371A 1997-10-27 1998-10-22 Dofetilide polymorphs AP906A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9722662.5A GB9722662D0 (en) 1997-10-27 1997-10-27 Polymorphs

Publications (2)

Publication Number Publication Date
AP9801371A0 AP9801371A0 (en) 1998-12-31
AP906A true AP906A (en) 2000-11-30

Family

ID=10821150

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1998/001371A AP906A (en) 1997-10-27 1998-10-22 Dofetilide polymorphs

Country Status (47)

Country Link
US (1) US6124363A (de)
EP (1) EP1027329B1 (de)
JP (1) JP3569495B2 (de)
KR (1) KR100366167B1 (de)
CN (1) CN1146537C (de)
AP (1) AP906A (de)
AR (1) AR015193A1 (de)
AT (1) ATE232199T1 (de)
AU (1) AU737668B2 (de)
BG (1) BG64125B1 (de)
BR (1) BR9813308A (de)
CA (1) CA2307121C (de)
CO (1) CO4970768A1 (de)
DE (1) DE69811256T2 (de)
DK (1) DK1027329T3 (de)
DZ (1) DZ2632A1 (de)
EA (1) EA002656B1 (de)
ES (1) ES2190620T3 (de)
GB (1) GB9722662D0 (de)
GT (1) GT199800165A (de)
HK (1) HK1033933A1 (de)
HN (1) HN1998000165A (de)
HR (1) HRP20000247B1 (de)
HU (1) HUP0004735A3 (de)
ID (1) ID24658A (de)
IL (1) IL135435A0 (de)
IS (1) IS2179B (de)
MA (1) MA24683A1 (de)
MY (1) MY123352A (de)
NO (1) NO325630B1 (de)
NZ (1) NZ503785A (de)
OA (1) OA11350A (de)
PA (1) PA8462001A1 (de)
PE (1) PE122199A1 (de)
PL (1) PL197379B1 (de)
PT (1) PT1027329E (de)
SA (1) SA98190834B1 (de)
SI (1) SI1027329T1 (de)
SK (1) SK5862000A3 (de)
TN (1) TNSN98193A1 (de)
TR (1) TR200001135T2 (de)
TW (1) TW449589B (de)
UA (1) UA67755C2 (de)
UY (2) UY25222A1 (de)
WO (1) WO1999021829A1 (de)
YU (1) YU24000A (de)
ZA (1) ZA989719B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10019067C1 (de) * 2000-04-18 2001-10-04 Lohmann Therapie Syst Lts Transdermales Therapeutisches System zur Abgabe von Dofetilid und seine Verwendung
US7326772B2 (en) * 2005-05-12 2008-02-05 Penta Biotech, Inc. Peptide for assaying hERG channel binding
CZ2017772A3 (cs) 2017-12-01 2019-05-29 Farmak, A.S. Způsob přípravy N-[4-(2-{[2-(4-methansulfonamidofenoxy)ethyl](methyl)amino}ethyl)fenyl]methansulfonamidu (Dofetilidu)
US11696902B2 (en) 2018-08-14 2023-07-11 AltaThera Pharmaceuticals, LLC Method of initiating and escalating sotalol hydrochloride dosing
US11610660B1 (en) 2021-08-20 2023-03-21 AltaThera Pharmaceuticals LLC Antiarrhythmic drug dosing methods, medical devices, and systems

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0245997A2 (de) * 1986-05-01 1987-11-19 Pfizer Limited N-substituierte p-Aminoethylsulfonanilide als antiarrhythmische Mittel und Zwischenprodukte dafür

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0898964A1 (de) * 1997-08-19 1999-03-03 Pfizer Inc. Methode zur Behandlung von Herzversagen

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0245997A2 (de) * 1986-05-01 1987-11-19 Pfizer Limited N-substituierte p-Aminoethylsulfonanilide als antiarrhythmische Mittel und Zwischenprodukte dafür

Also Published As

Publication number Publication date
MA24683A1 (fr) 1999-07-01
SK5862000A3 (en) 2001-10-08
CA2307121A1 (en) 1999-05-06
EA200000365A1 (ru) 2000-12-25
JP3569495B2 (ja) 2004-09-22
GB9722662D0 (en) 1997-12-24
ID24658A (id) 2000-07-27
KR20010031439A (ko) 2001-04-16
YU24000A (sh) 2003-02-28
AR015193A1 (es) 2001-04-18
TW449589B (en) 2001-08-11
WO1999021829A1 (en) 1999-05-06
EA002656B1 (ru) 2002-08-29
UY25341A1 (es) 1999-09-27
CN1278246A (zh) 2000-12-27
AU737668B2 (en) 2001-08-30
HUP0004735A3 (en) 2001-12-28
CO4970768A1 (es) 2000-11-07
AU2151299A (en) 1999-05-17
SI1027329T1 (en) 2003-04-30
AP9801371A0 (en) 1998-12-31
KR100366167B1 (ko) 2003-01-09
DK1027329T3 (da) 2003-02-24
BG64125B1 (bg) 2004-01-30
NO325630B1 (no) 2008-06-30
EP1027329B1 (de) 2003-02-05
HRP20000247B1 (en) 2002-08-31
NZ503785A (en) 2004-11-26
DZ2632A1 (fr) 2003-03-08
EP1027329A1 (de) 2000-08-16
JP2001521023A (ja) 2001-11-06
BR9813308A (pt) 2000-08-22
ATE232199T1 (de) 2003-02-15
UA67755C2 (uk) 2004-07-15
ES2190620T3 (es) 2003-08-01
IL135435A0 (en) 2001-05-20
SA98190834B1 (ar) 2006-08-21
US6124363A (en) 2000-09-26
BG104373A (en) 2000-12-29
TNSN98193A1 (fr) 2005-03-15
OA11350A (en) 2003-12-17
HRP20000247A2 (en) 2000-10-31
TR200001135T2 (tr) 2000-09-21
HN1998000165A (es) 1999-02-09
DE69811256T2 (de) 2003-09-18
IS2179B (is) 2006-12-15
HK1033933A1 (en) 2001-10-05
UY25222A1 (es) 2000-12-29
NO20002191L (no) 2000-04-27
PL340805A1 (en) 2001-02-26
MY123352A (en) 2006-05-31
NO20002191D0 (no) 2000-04-27
IS5426A (is) 2000-03-31
CN1146537C (zh) 2004-04-21
PE122199A1 (es) 1999-12-02
PA8462001A1 (es) 2000-05-24
PT1027329E (pt) 2003-04-30
DE69811256D1 (de) 2003-03-13
GT199800165A (es) 2000-04-19
CA2307121C (en) 2006-12-05
ZA989719B (en) 2000-04-26
HUP0004735A2 (hu) 2001-10-28
PL197379B1 (pl) 2008-03-31

Similar Documents

Publication Publication Date Title
EA023374B1 (ru) 4-(8-метокси-1-((1-метоксипропан-2-ил)-2-(тетрагидро-2н-пиран-4-ил)-1н-имидазо[4,5-c]хинолин-7-ил)-3,5-диметилизоксазол и его применение в качестве ингибитора бромодомена
JP2823356B2 (ja) 神経筋遮断剤
TW202106680A (zh) Glyt1抑制劑之固體形式
DE3875600T2 (de) Antiarrythmische derivate 2.
AP906A (en) Dofetilide polymorphs
EP0161599A2 (de) Neue Benzazepinderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
JPS6126996B2 (de)
EP0074014A1 (de) 2-(2'-Hydroxy-3'-(1,1-dimethylpropylamino)-propoxy)-beta-phenylpropiophenon, seine Säureadditionssalze, Verfahren zu seiner Herstellung und Arzneimittel
DE69022442T2 (de) Aminoalkoxyphenyl-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Zusammensetzungen.
EP0011747B1 (de) Aminopropanolderivate des 6-Hydroxy-2,3,4,5-tetrahydro-1H-1-benzazepin-2-ons, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
MXPA00004059A (en) Dofetilide polymorphs
PT2370440E (pt) Anidrato de 8-cloro-3-pentil-3,7-di-hidro-1h-purino-2,6- diona 2-amino-2-(hidroximetil)-1,3-propanodiol para o tratamento de doenças
JP2022517396A (ja) Ｅｇｆｒ阻害剤の塩、結晶形及びその製造方法
JP2507764B2 (ja) 低級アルキルスルフアモイルアミン類、その塩およびその用途
EP2649996A1 (de) Kristalline Sartansformen wie Telmisartan und Betablocker
CZ20001516A3 (cs) Polymorfy dofetilidu
CN112851599B (zh) 一种具有双阳离子季铵盐结构的化合物及其制备方法和用途
EP3912971A1 (de) Cholinesterase-inhibitor-polymorph und anwendung davon
EP3939578A1 (de) Verbindungen zur behandlung oder vorbeugung einer infektion, die aus einer coronavirus- und/oder einer coronavirusinduzierten erkrankung resultiert
JPH01175937A (ja) 不整脈治療剤
PT1641797E (pt) Mesilato de hidrogénio de 4-(4-trans-hidroxicicloexil) amino-2-fenil-7h-pirroloii2,3d] pirimidina e suas formas polimórficas
DE3689086T2 (de) 1,4-Dihydropyridin-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Zusammensetzung und ihre Verwendung.
DE3421252A1 (de) 1-phenoxy-3- hydroxyindolylalkylamino-3-propanolverbindungen, verfahren zu ihrer herstellung und pharmazeutische mittel, die diese verbindungen enthalten
WO1999009001A1 (fr) Derives de phenylethanolaminotetraline et bronchodilatateurs
WO2013103004A1 (ja) （２ｅ）－３－（１ｈ－インダゾール－３－イル）－ｎ－（３－メトキシフェニル）－ｎ－［３－（メチルスルホニル）プロピル］ブト－２－エンアミドの結晶形